Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma.
| Publicado en: | Journal of Clinical Oncology Vol. 44; pp. 374 - 561 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2026 Supplsmsnr 2
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190829341&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 190829341 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2026 Supplsmsnr 2 vid: 44 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 190829341 10.1200/JCO.2026.44.2_suppl.374 190829341 ppf: 374 ppct: 187 formats: tig: atl: Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma. aug: au: Zhen, David Bing Maziarz, Richard T. Chen, Emerson Yu-sheng Fountzilas, Christos Kim, Dae Won Gutierrez, Martin Gibson, Michael K. DeVito, Nicholas C. Phan, Alexandria T. Oshrine, Benjamin Koneru, Mythili Vahora, Sahista Wang, Chuan Xin, Lijun Davis, Christian Zhang, Jinghui Shields, Anthony F. affil: Fred Hutchinson Cancer Center, Seattle, WA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|